Home » Topics » BioWorld Science

BioWorld Science
RSS

Immunogenicity aids chemotherapy as well

March 28, 2019

Human TRIM5-alpha active against HIV

March 28, 2019

Foscavir approved in Japan to treat HHV-6 encephalitis

March 27, 2019

AnGes obtains conditional approval in Japan for HGF plasmid in critical limb ischemia

March 27, 2019

NBE-Therapeutics describes antibody product targeting ROR1

March 27, 2019

IMV reports preliminary phase II data for DPX-Survivac in ovarian cancer

March 27, 2019

Phase II trial of Triplex for CMV complications in HSCT recipients meets primary endpoint

March 27, 2019

Revcovi approved in Japan for ADA deficiency

March 27, 2019

Boronated analogues of pleuromutilins show promise for filarial infections in vivo

March 27, 2019

FDA approves Mayzent for relapsing forms of MS

March 27, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...